BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Okajima W, Komatsu S, Ichikawa D, Miyamae M, Ohashi T, Imamura T, Kiuchi J, Nishibeppu K, Arita T, Konishi H, Shiozaki A, Morimura R, Ikoma H, Okamoto K, Otsuji E. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids. World J Gastroenterol 2017; 23(31): 5650-5668 [PMID: 28883691 DOI: 10.3748/wjg.v23.i31.5650]
URL: https://www.wjgnet.com/1007-9327/full/v23/i31/5650.htm
Number Citing Articles
1
Lucas Trevisan França de Lima, Daniel Broszczak, Xi Zhang, Kim Bridle, Darrell Crawford, Chamindie Punyadeera. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinomaBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188451 doi: 10.1016/j.bbcan.2020.188451
2
Annarita Perillo, Mohamed Vincenzo Agbaje Olufemi, Jacopo De Robbio, Rossella Margherita Mancuso, Anna Roscigno, Maddalena Tirozzi, Ida Rosalia Scognamiglio. Liquid biopsy in NSCLC: a new challenge in radiation therapyExploration of Targeted Anti-tumor Therapy 2021;  doi: 10.37349/etat.2021.00038
3
Leonardo Gomes da Fonseca, Raphael L C Araujo. Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalitiesWorld Journal of Gastroenterology 2022; 28(28): 3573-3585 doi: 10.3748/wjg.v28.i28.3573
4
Sophie Schlosser, Deniz Tümen, Barbara Volz, Katja Neumeyer, Niklas Egler, Claudia Kunst, Hauke Christian Tews, Stephan Schmid, Arne Kandulski, Martina Müller, Karsten Gülow. HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practiceFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1016952
5
Jelena Mann, Helen L Reeves, Ariel E Feldstein. Liquid biopsy for liver diseasesGut 2018; 67(12): 2204 doi: 10.1136/gutjnl-2017-315846
6
Xuenan Peng, Caifeng Gong, Wen Zhang, Aiping Zhou. Advanced development of biomarkers for immunotherapy in hepatocellular carcinomaFrontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1091088
7
Atsunori Tsuchiya, Masahiro Ogawa, Takayuki Watanabe, Suguru Takeuchi, Yuichi Kojima, Yusuke Watanabe, Naruhiro Kimura, Kazunao Hayashi, Junji Yokoyama, Shuji Terai. Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinomaHeliyon 2019; 5(3): e01325 doi: 10.1016/j.heliyon.2019.e01325
8
Ning Li, Ling Li, Yongshun Chen. The Identification of Core Gene Expression Signature in Hepatocellular CarcinomaOxidative Medicine and Cellular Longevity 2018; 2018: 1 doi: 10.1155/2018/3478305
9
Liang-Chun Yin, Zhen-Chao Luo, Yan-Xin Gao, Yang Li, Qing Peng, Yi Gao. Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and PrognosesBioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3789613
10
Víctor Amado, Sandra González-Rubio, Javier Zamora, Rafael Alejandre, María Lola Espejo-Cruz, Clara Linares, Marina Sánchez-Frías, Gema García-Jurado, José Luis Montero, Rubén Ciria, Manuel Rodríguez-Perálvarez, Gustavo Ferrín, Manuel De la Mata. Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver TransplantationCancers 2021; 13(10): 2476 doi: 10.3390/cancers13102476
11
Hugo A. Barrera-Saldaña, Luis E. Fernández-Garza, Silvia A. Barrera-Barrera. Liquid biopsy in chronic liver diseaseAnnals of Hepatology 2021; 20: 100197 doi: 10.1016/j.aohep.2020.03.008
12
Gurjot Singh, Eric M Yoshida, Sahaj Rathi, Vladimir Marquez, Peter Kim, Siegfried R Erb, Baljinder S Salh. Biomarkers for hepatocellular cancerWorld Journal of Hepatology 2020; 12(9): 558-573 doi: 10.4254/wjh.v12.i9.558
13
Sinisa Bratulic, Francesco Gatto, Jens Nielsen. The Translational Status of Cancer Liquid BiopsiesRegenerative Engineering and Translational Medicine 2021; 7(3): 312 doi: 10.1007/s40883-019-00141-2
14
Qi Zhang, Yu Lou, Xue-Li Bai, Ting-Bo Liang. Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studiesWorld Journal of Gastroenterology 2020; 26(26): 3720-3736 doi: 10.3748/wjg.v26.i26.3720
15
Sally Temraz, Rihab Nasr, Deborah Mukherji, Firas Kreidieh, Ali Shamseddine. Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinomaExpert Review of Molecular Diagnostics 2022; 22(5): 507 doi: 10.1080/14737159.2022.2094706
16
Matthias Pinter, Markus Peck‐Radosavljevic. Review article: systemic treatment of hepatocellular carcinomaAlimentary Pharmacology & Therapeutics 2018; 48(6): 598 doi: 10.1111/apt.14913
17
Joseph C. Ahn, Pai‐Chi Teng, Pin‐Jung Chen, Edwin Posadas, Hsian‐Rong Tseng, Shelly C. Lu, Ju Dong Yang. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular CarcinomaHepatology 2021; 73(1): 422 doi: 10.1002/hep.31165
18
Jumi Kang, Soon Sun Kim. Current Status and Prospects of Liquid Biopsy for Hepatocellular CarcinomaThe Korean Journal of Gastroenterology 2023; 82(1): 1 doi: 10.4166/kjg.2023.076
19
Matthias Ocker. Biomarkers for hepatocellular carcinoma: What’s new on the horizon?World Journal of Gastroenterology 2018; 24(35): 3974-3979 doi: 10.3748/wjg.v24.i35.3974
20
Yi-Ping Hung, Yu-Yun Shao, Chiun Hsu, Chih-Hung Hsu, Jan-Mou Lee, Muh-Hwa Yang, Yee Chao. The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinomaJournal of the Formosan Medical Association 2021; 120(8): 1581 doi: 10.1016/j.jfma.2020.11.015
21
Matteo Canale, Paola Ulivi, Francesco Giuseppe Foschi, Emanuela Scarpi, Serena De Matteis, Gabriele Donati, Giorgio Ercolani, Mario Scartozzi, Luca Faloppi, Alessandro Passardi, Emiliano Tamburini, Martina Valgiusti, Giorgia Marisi, Giovanni Luca Frassineti, Andrea Casadei Gardini. Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinomaCritical Reviews in Oncology/Hematology 2018; 129: 44 doi: 10.1016/j.critrevonc.2018.06.017
22
Yao Chen, Haifeng Xie, Ting Xie, Xunjun Yang, Yilin Pang, SongDao Ye. Elevated Expression of PDZD11 Is Associated With Poor Prognosis and Immune Infiltrates in Hepatocellular CarcinomaFrontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.669928
23
Robert Stawski, Dariusz Nowak, Ewelina Perdas. Cell-Free DNA: Potential Application in COVID-19 Diagnostics and ManagementViruses 2022; 14(2): 321 doi: 10.3390/v14020321
24
Ling Li, Huijia Zhao, Binyao Chen, Kang Huang, Zhuowen Hao, Zhipeng Fan, Gongpeng Sun, Jianguo Wu, Ning Li, Qifa Ye, Jiang Yue. Noninvasive Identification of Immune-Related Biomarkers in Hepatocellular CarcinomaJournal of Oncology 2019; 2019: 1 doi: 10.1155/2019/2531932
25
Filippo Pelizzaro, Romilda Cardin, Barbara Penzo, Elisa Pinto, Alessandro Vitale, Umberto Cillo, Francesco Paolo Russo, Fabio Farinati. Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?Cancers 2021; 13(9): 2274 doi: 10.3390/cancers13092274
26
Olorunseun O Ogunwobi, Trisheena Harricharran, Jeannette Huaman, Anna Galuza, Oluwatoyin Odumuwagun, Yin Tan, Grace X Ma, Minhhuyen T Nguyen. Mechanisms of hepatocellular carcinoma progressionWorld Journal of Gastroenterology 2019; 25(19): 2279-2293 doi: 10.3748/wjg.v25.i19.2279
27
Kai-Qian Zhou, Yun-Fan Sun, Jian-Wen Cheng, Min Du, Yuan Ji, Peng-Xiang Wang, Bo Hu, Wei Guo, Yang Gao, Yue Yin, Jun-Feng Huang, Jian Zhou, Jia Fan, Xin-Rong Yang. Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinomaeBioMedicine 2020; 62: 103107 doi: 10.1016/j.ebiom.2020.103107
28
Yurika Kotoh, Yutaka Suehiro, Issei Saeki, Tomomi Hoshida, Masaki Maeda, Takuya Iwamoto, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Shingo Higaki, Ikuei Fujii, Chieko Suzuki, Yoshitaro Shindo, Yukio Tokumitsu, Hiroaki Nagano, Isao Sakaida, Takahiro Yamasaki. Novel Liquid Biopsy Test Based on a Sensitive Methylated SEPT9 Assay for Diagnosing Hepatocellular CarcinomaHepatology Communications 2020; 4(3): 461 doi: 10.1002/hep4.1469
29
Eiichiro Suzuki, Tetsuhiro Chiba, Naoya Kato. Biomarkers in Cancer Therapy2019; : 87 doi: 10.1007/978-981-13-7295-7_8
30
Qiong Luo, Chunming Wang, Bangjian Peng, Xiaoyu Pu, Lei Cai, Hangyu Liao, Kunling Chen, Cheng Zhang, Yuan Cheng, Mingxin Pan. Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular CarcinomaFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01758
31
Juan Hu, Wubo Ren, Han Liu, Cong Xie, Dandan Li, Liping Yang, Fangli Liao, Linshan Jiang, Qinli Pu, Weixian Chen. Immunomultiple PCR-based electrochemical and lateral flow strategy for the simultaneous detection of liver cancer tumor markersMicrochimica Acta 2024; 191(1) doi: 10.1007/s00604-023-06098-y
32
Guo Long, Tongdi Fang, Wenxin Su, Xingyu Mi, LeDu Zhou. The prognostic value of postoperative circulating cell-free DNA in operable hepatocellular carcinomaScandinavian Journal of Gastroenterology 2020; 55(12): 1441 doi: 10.1080/00365521.2020.1839127
33
Lingli Sun, Yuanlong Zhang, Wenji Zhang, Xingfei Lai, Qiuhua Li, Lingyun Zhang, Shili Sun. Green tea and black tea inhibit proliferation and migration of HepG2 cells via the PI3K/Akt and MMPs signalling pathwayBiomedicine & Pharmacotherapy 2020; 125: 109893 doi: 10.1016/j.biopha.2020.109893
34
Michihiro Kudou, Toshiyuki Kosuga, Eigo Otsuji. Artificial intelligence in gastrointestinal cancer: Recent advances and future perspectivesArtificial Intelligence in Gastroenterology 2020; 1(4): 71-85 doi: 10.35712/aig.v1.i4.71
35
Valerie Paradis, Jessica Zucman-Rossi. MacSween's Pathology of the Liver2024; : 96 doi: 10.1016/B978-0-7020-8228-3.00002-8
36
Marianna Alunni-Fabbroni, Kerstin Rönsch, Thomas Huber, Clemens C. Cyran, Max Seidensticker, Julia Mayerle, Maciej Pech, Bristi Basu, Chris Verslype, Julia Benckert, Peter Malfertheiner, Jens Ricke. Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trialJournal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-2079-9
37
Bo Kong, Helmut Friess. Translational Pancreatic Cancer ResearchMolecular and Translational Medicine 2020; : 97 doi: 10.1007/978-3-030-49476-6_6
38
Feifei Wei, Liang Yang, Dandan Jiang, Min Pan, Guiyan Tang, Mingyue Huang, Jing Zhang. Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR‐422a/PDK2 axisCancer Medicine 2020; 9(7): 2480 doi: 10.1002/cam4.2861
39
Yang Zhang, Yan Yang, Yi Zhang, Zhisu Liu. lncRNA ST8SIA6‑AS1 facilitates proliferation and invasion in liver cancer by regulating miR‑142‑3pExperimental and Therapeutic Medicine 2021; 22(6) doi: 10.3892/etm.2021.10783
40
Wang Yinzhong, Wang Miaomiao, Tian Xiaoxue, Wang Qian, Qi Meng, Lei Junqiang. Diagnostic accuracy of circulating-free DNA for the determination of hepatocellular carcinoma: a systematic review and meta-analysisExpert Review of Molecular Diagnostics 2023; 23(1): 63 doi: 10.1080/14737159.2023.2167555
41
I. F. Kustova, A. S. Makarova, N. L. Lazarevich. Potential of the use of methylation biomarkers for diagnostics and prognosis of hepatocellular carcinoma in liquid biopsyAdvances in molecular oncology 2019; 5(4): 8 doi: 10.17650/2313-805X-2018-5-4-8-19
42
Defeng Kong, Wen Zhang, Zhenrong Yang, Guoliang Li, Shujun Cheng, Kaitai Zhang, Lin Feng. Correlation between PD-L1 expression ON CTCs and prognosis of patients with cancer: a systematic review and meta-analysisOncoImmunology 2021; 10(1) doi: 10.1080/2162402X.2021.1938476
43
Xiaoke Wu, Mengmeng Shi, Yajun Lian, Haifeng Zhang. Exosomal circRNAs as promising liquid biopsy biomarkers for gliomaFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1039084
44
Ioana Manea, Razvan Iacob, Speranta Iacob, Razvan Cerban, Simona Dima, Gabriel Oniscu, Irinel Popescu, Liliana Gheorghe. Liquid biopsy for early detection of hepatocellular carcinomaFrontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1218705
45
Tudor Mocan, André L. Simão, Rui E. Castro, Cecília M. P. Rodrigues, Artur Słomka, Bingduo Wang, Christian Strassburg, Aliona Wöhler, Arnulf G. Willms, Miroslaw Kornek. Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?Journal of Clinical Medicine 2020; 9(5): 1541 doi: 10.3390/jcm9051541
46
Yuanwen Chen, Ping Xu, Weiqing Qiu, Hongyi Zhu, Changlin Qian, Huojian Shen, Jie Zhang. Gastric Cancer-Circulating Tumor Cells Isolation by Folic Acid Immunolipid Magnetic Beads and Clinical ApplicationScience of Advanced Materials 2022; 14(6): 1024 doi: 10.1166/sam.2022.4282
47
Chun Ning, Peng Cai, Xiaofan Liu, Guangtao Li, Pengfei Bao, Lu Yan, Meng Ning, Kaichen Tang, Yi Luo, Hua Guo, Yunjiu Wang, Zhuoran Wang, Lu Chen, Zhi John Lu, Jianhua Yin. A comprehensive evaluation of full-spectrum cell-free RNAs highlights cell-free RNA fragments for early-stage hepatocellular carcinoma detectioneBioMedicine 2023; 93: 104645 doi: 10.1016/j.ebiom.2023.104645
48
Shucai Xie, Xili Jiang, Jianquan Zhang, Shaowei Xie, Yongyong Hua, Rui Wang, Yijun Yang. Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysisPeerJ 2019; 7: e7408 doi: 10.7717/peerj.7408
49
July Rodríguez, Jenny Avila, Christian Rolfo, Alejandro Ruíz-Patiño, Alessandro Russo, Luisa Ricaurte, Camila Ordóñez-Reyes, Oscar Arrieta, Zyanya Lucia Zatarain-Barrón, Gonzalo Recondo, Andrés F. Cardona. When Tissue is an Issue the Liquid Biopsy is Nonissue: A ReviewOncology and Therapy 2021; 9(1): 89 doi: 10.1007/s40487-021-00144-6
50
Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNAMolecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1043-x
51
Zheyu Zhou, Xiaoliang Xu, Yang Liu, Qiaoyu Liu, Wenjie Zhang, Kun Wang, Jincheng Wang, Yin Yin. Liquid BiopsiesMethods in Molecular Biology 2023; 2695: 213 doi: 10.1007/978-1-0716-3346-5_14
52
Andrea Casadei-Gardini, Orsi Giulia, Caputo Francesco, Ercolani Giorgio. Developments in predictive biomarkers for hepatocellular carcinoma therapyExpert Review of Anticancer Therapy 2020; 20(1): 63 doi: 10.1080/14737140.2020.1712198
53
Wen-Ying Yang, Lin-Fei Feng, Xiang Meng, Ran Chen, Wen-Hua Xu, Jun Hou, Tao Xu, Lei Zhang. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomesExpert Review of Molecular Diagnostics 2020; 20(12): 1213 doi: 10.1080/14737159.2020.1855977
54
Ying-Hsiu Su, Amy K. Kim, Surbhi Jain. Liquid biopsies for hepatocellular carcinomaTranslational Research 2018; 201: 84 doi: 10.1016/j.trsl.2018.07.001
55
María Lola Espejo-Cruz, Sandra González-Rubio, Javier Zamora-Olaya, Víctor Amado-Torres, Rafael Alejandre, Marina Sánchez-Frías, Rubén Ciria, Manuel De la Mata, Manuel Rodríguez-Perálvarez, Gustavo Ferrín. Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical AppraisalInternational Journal of Molecular Sciences 2021; 22(23): 13073 doi: 10.3390/ijms222313073
56
Kewen He, Shaotong Zhang, Liang L. Shao, Jiani C. Yin, Xue Wu, Yang W. Shao, Shuanghu Yuan, Jinming Yu. Developing more sensitive genomic approaches to detect radioresponse in precision radiation oncology: From tissue DNA analysis to circulating tumor DNACancer Letters 2020; 472: 108 doi: 10.1016/j.canlet.2019.12.004
57
Rasha Elzehery, Narmin Effat, Reham El Farahaty, Raghda Elsayed Farag, Ekbal M Abo-Hashem, Rania Elhelaly. Circulating Cell-Free DNA and DNA Integrity as Molecular Diagnostic Tools in Hepatocellular CarcinomaAmerican Journal of Clinical Pathology 2022; 158(2): 254 doi: 10.1093/ajcp/aqac037
58
Omid Gholizadeh, Hossein Bannazadeh Baghi, Mahin Ahangar Oskouee, Nader Mohammadzadeh, Behrooz Naghili, Narges Eslami, Mohsen Nasiri-toosi, Alka Hasani, Mohammad Ahngarzadeh Rezaei, Tina Taikandi, Vahdat Poortahmasebi. Comparative Transcriptional Signature Analysis of Peripheral Blood Mononuclear Cells in Early Stage of Hepatitis B-related Hepatocellular CarcinomaHepatitis Monthly 2023; 22(1) doi: 10.5812/hepatmon-130862
59
Shijie Li, Kerong Xin, Shen Pan, Yang Wang, Jianyi Zheng, Zeyu Li, Xuefeng Liu, Bitian Liu, Zhenqun Xu, Xiaonan Chen. Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancerCellular & Molecular Biology Letters 2023; 28(1) doi: 10.1186/s11658-023-00442-z
60
Luciana Santos Pessoa, Manoela Heringer, Valéria Pereira Ferrer. ctDNA as a cancer biomarker: A broad overviewCritical Reviews in Oncology/Hematology 2020; 155: 103109 doi: 10.1016/j.critrevonc.2020.103109
61
Irun Bhan, Daniel A. Haber, Raymond T. Chung, David T. Ting. Hepatocellular CarcinomaMolecular and Translational Medicine 2019; : 125 doi: 10.1007/978-3-030-21540-8_7
62
Mehrdad Ameri, Haniye Salimi, Sedigheh Eskandari, Navid Nezafat. Identification of potential biomarkers in hepatocellular carcinoma: A network-based approachInformatics in Medicine Unlocked 2022; 28: 100864 doi: 10.1016/j.imu.2022.100864
63
Onyinye Ugonabo, Utibe-Abasi Sunday Udoh, Pradeep Kumar Rajan, Heather Reeves, Christina Arcand, Yuto Nakafuku, Tejas Joshi, Rob Finley, Sandrine V. Pierre, Juan Ramon Sanabria. The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future DirectionsBiomolecules 2023; 13(9): 1369 doi: 10.3390/biom13091369
64
Francesca Carissimi, Matteo Nazzareno Barbaglia, Livia Salmi, Cristina Ciulli, Linda Roccamatisi, Giuseppe Cordaro, Venkata Ramana Mallela, Rosalba Minisini, Biagio Eugenio Leone, Matteo Donadon, Guido Torzilli, Mario Pirisi, Fabrizio Romano, Simone Famularo. Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatmentWorld Journal of Gastrointestinal Surgery 2021; 13(9): 967-978 doi: 10.4240/wjgs.v13.i9.967